Target intelligence / Profile preview

Envelope glycoprotein gp160 (gp160)

Target
gp160
Molecular classification
Viral envelope protein, Class I viral fusion protein, Glycoprotein
01

Overview

The HIV-1 envelope glycoprotein gp160 is a crucial viral protein synthesized as a precursor in the rough endoplasmic reticulum of infected host cells. It oligomerizes into trimers and is subsequently cleaved by host cell furin-like proteases in the Golgi apparatus into two non-covalently associated subunits: the surface subunit gp120 and the transmembrane subunit gp41. Together, these subunits form the mature envelope spike on the virion surface, which is essential for viral entry. The gp120 subunit mediates initial attachment to the host CD4 receptor and chemokine co-receptors (CCR5 or CXCR4), while gp41 facilitates the subsequent fusion of the viral and host cell membranes. Truncated variants, such as gp150, are engineered by removing the cytoplasmic tail to enhance surface expression and stability, making them valuable tools in vaccine design and structural studies.

As the sole viral antigen exposed on the surface of HIV-1 virions, gp160 is a primary target for both therapeutic interventions and vaccine development. Antiretroviral drugs target different subunits of gp160 to block viral entry; for example, fostemsavir (and its active form temsavir) acts as an attachment inhibitor by binding to gp120, while enfuvirtide and albuvirtide act as fusion inhibitors by binding to gp41. Additionally, gp160 is the target of broadly neutralizing antibodies (bnAbs) such as VRC01, 3BNC117, and 10-1074, which are being evaluated in clinical trials for passive immunization and viral suppression. However, the high mutation rate of HIV-1 leads to rapid conformational changes and glycan shielding, presenting significant challenges for vaccine efficacy and the development of drug resistance.

Other names
gp160gp150HIV-1 EnvEnvelope glycoproteingp120/gp41gp120/gp41 envelope glycoproteinHIV-1 Env gp150/gp160
02

Mechanism of action

Inhibition of viral attachment to host CD4 receptors (e.g., by binding to the gp120 subunit) or inhibition of viral-host membrane fusion (e.g., by binding to the gp41 subunit).

03

Biological functions

Viral entryHost cell attachmentMembrane fusionReceptor bindingImmune response
04

Disease associations

InfectionAcquired Immunodeficiency Syndrome (AIDS)
05

Safety considerations

Rapid development of drug resistance due to high mutation rate of HIV-1Immune Reconstitution Inflammatory Syndrome (IRIS)Hepatotoxicity (especially in patients co-infected with HBV or HCV)QTc prolongation (at high doses of certain inhibitors like fostemsavir)Injection site reactions (for peptide fusion inhibitors like enfuvirtide)
06

Interacting drugs

7 more in the full profile.

07

Biomarkers

Viral load (HIV-1 RNA)CD4+ T-cell countgp160/gp120/gp41 sequence mutations (resistance testing)

Beyond the preview

Go deeper on Envelope glycoprotein gp160 (gp160).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Envelope glycoprotein gp160 (gp160).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call